| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Pathogenicity and Medical Microbiology |
Department of Molecular and Cell Biology, Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, UK1
Department of Bacteriology and Mycology, Janssen Research Foundation,B-2340 Beerse, Belgium2
Author for correspondence: Frank C. Odds. Tel: +44 1224 273128. Fax: +44 1224 273144. e-mail: f.odds{at}abdn.ac.uk
Evidence is presented that the growth medium used to prepare a Candida albicans challenge inoculum is a significant factor determining the ability of a fungus strain to gain an initial invasive hold immediately after injection into an animal host, and thus determining gross strain lethality. Three C. albicans strains, one known to be attenuated in virulence, were grown in two broth media and injected intravenously at different doses into female NMRI mice and male albino guinea pigs. For each fungus strain and challenge dose, survival was longer from inocula grown in a diluted, buffered peptone-based broth than from inocula grown in Sabouraud glucose broth. When animals were challenged intravenously with yeast doses adjusted to give the same mean survival time regardless of strain or growth medium, the progression of fungus tissue burdens (c.f.u. g-1) in kidneys, lungs, liver, spleen and brain samples was broadly similar for all three C. albicans strains but differed between the two animal hosts. The morphological form of C. albicans recovered from infected tissues differed at the level of both the fungus strain and the host tissue. Use of survival-standardized inocula provides a means of distinguishing differences in progression of experimental disseminated Candida infections that are related to the infecting strain from those related to the animal host.
Keywords: Candida albicans, experimental infection, virulence
Abbreviations: MI, morphology index
This article has been cited by other articles:
|
|
 |
|
  S. Bates, J. M. de la Rosa, D. M. MacCallum, A. J. P. Brown, N. A. R. Gow, and F. C. Odds Candida albicans Iff11, a Secreted Protein Required for Cell Wall Structure and Virulence Infect. Immun., June 1, 2007; 75(6): 2922 - 2928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. M. L. P. Navarathna, J. M. Hornby, N. Krishnan, A. Parkhurst, G. E. Duhamel, and K. W. Nickerson Effect of Farnesol on a Mouse Model of Systemic Candidiasis, Determined by Use of a DPP3 Knockout Mutant of Candida albicans Infect. Immun., April 1, 2007; 75(4): 1609 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nett, L. Lincoln, K. Marchillo, R. Massey, K. Holoyda, B. Hoff, M. VanHandel, and D. Andes Putative Role of {beta}-1,3 Glucans in Candida albicans Biofilm Resistance Antimicrob. Agents Chemother., February 1, 2007; 51(2): 510 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Thewes, H.-K. Reed, C. Grosse-Siestrup, D. A. Groneberg, M. Meissler, M. Schaller, and B. Hube Haemoperfused liver as an ex vivo model for organ invasion of Candida albicans J. Med. Microbiol., February 1, 2007; 56(2): 266 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Odds, A. D. Davidson, M. D. Jacobsen, A. Tavanti, J. A. Whyte, C. C. Kibbler, D. H. Ellis, M. C. J. Maiden, D. J. Shaw, and N. A. R. Gow Candida albicans Strain Maintenance, Replacement, and Microvariation Demonstrated by Multilocus Sequence Typing. J. Clin. Microbiol., October 1, 2006; 44(10): 3647 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Brown, J. A. Sexton, and M. Johnston A Glucose Sensor in Candida albicans. Eukaryot. Cell, October 1, 2006; 5(10): 1726 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cornet, F. Bidard, P. Schwarz, G. Da Costa, S. Blanchin-Roland, F. Dromer, and C. Gaillardin Deletions of Endocytic Components VPS28 and VPS32 Affect Growth at Alkaline pH and Virulence through both RIM101-Dependent and RIM101-Independent Pathways in Candida albicans Infect. Immun., December 1, 2005; 73(12): 7977 - 7987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Sharkey, W.-l. Liao, A. K. Ghosh, and W. A. Fonzi Flanking direct repeats of hisG alter URA3 marker expression at the HWP1 locus of Candida albicans Microbiology, April 1, 2005; 151(4): 1061 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A Schofield, C. Westwater, and E. Balish Divergent chemokine, cytokine and {beta}-defensin responses to gastric candidiasis in immunocompetent C57BL/6 and BALB/c mice J. Med. Microbiol., January 1, 2005; 54(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Monteagudo, A Viudes, A Lazzell, J P Martinez, and J L Lopez-Ribot Tissue invasiveness and non-acidic pH in human candidiasis correlate with "in vivo" expression by Candida albicans of the carbohydrate epitope recognised by new monoclonal antibody 1H4 J. Clin. Pathol., June 1, 2004; 57(6): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Alarco, A. Marcil, J. Chen, B. Suter, D. Thomas, and M. Whiteway Immune-Deficient Drosophila melanogaster: A Model for the Innate Immune Response to Human Fungal Pathogens J. Immunol., May 1, 2004; 172(9): 5622 - 5628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Barelle, E. A. Bohula, S. J. Kron, D. Wessels, D. R. Soll, A. Schafer, A. J. P. Brown, and N. A. R. Gow Asynchronous Cell Cycle and Asymmetric Vacuolar Inheritance in True Hyphae of Candida albicans Eukaryot. Cell, June 1, 2003; 2(3): 398 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Newport, A. Kuo, A. Flattery, C. Gill, J. J. Blake, M. B. Kurtz, G. K. Abruzzo, and N. Agabian Inactivation of Kex2p Diminishes the Virulence of Candida albicans J. Biol. Chem., January 10, 2003; 278(3): 1713 - 1720. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
